Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus

Journal of Clinical Investigation

Volumn 102, Issue 7, 1998, Pages 1431-1443

  Fleck, Martin ^a,b   Kern, Earl R ^c   Zhou, Tong ^b   Podlech, Jürgen ^d   Wintersberger, Winfried ^b   Edwards III, Carl K ^e   Mountz, John D ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b The University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e AMGEN INC   (United States)

Author keywords

Apoptosis; Fas; lpr mice; MCMV; TNF R1 knockout mice

Indexed keywords

AUTOANTIBODY; CYTOKINE; DNA ANTIBODY; DOUBLE STRANDED DNA; FAS ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTION; FEMALE; IMMUNE RESPONSE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0032190589     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3248     Document Type: Article

References (86)

1. Britt, W.J., and C.A. Alford. 1996. Chapter 15. In Fields Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven, Philadelphia, PA. 2493-2523.
2. Messerle, M., G.M. Keil, K. Schneider, and U.H. Koszinowski. 1992. Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog. Virology. 191:355-367.
3. Hudson, J.B. 1979. The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Arch. Virol. 62:1-29.
4. Tanaka, K., Y. Koga, Y.Y. Lu, X.Y. Zhang, Y. Wang, G. Kimura, and K. Nomoto. 1994. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus. J. Clin. Invest. 94:1019-1025.
5. Quinnan, G.V., J.E. Manischewitz, and F.A. Ennis. 1978. Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature. 273:541-543.
6. Selgrade, M.K., Y.S. Huang, J.A. Graham, C.H. Huang, and P.C. Hu. 1983. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection. J. Immunol. 131:3032-3035.
7. Koszinowski, U.H., G.M. Keil, H. Schwarz, J. Schickedanz, and M.J. Reddehase. 1987. A nonstructural polypeptide encoded by immediate-early transcription unit 1 of murine cytomegalovirus is recognized by cytolytic T lymphocytes. J. Exp. Med. 166:289-294.
8. Heise, M.T., and H.W. Virgin. 1995. The T cell independent role of IFN-gamma and TNF-alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infection. J. Virol. 69:904-909.
9. Orange, J.S., B. Wang, C. Terhorst, and A.B. Biron. 1995. Requirement for natural killer cell-produced Interferon-γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
10. Banks, T.A., and B.T. Rouse. 1992. Herpesviruses-immune escape artists. Clin. Infect. Dis. 14:933-941.
11. Spriggs, M.K. 1996. One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol. 14:101-130.
12. Rawlinson, W.D., H.E. Farell, and B.G. Barell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol. 70:8833-8849.
13. Farell, H.E., H. Vally, D.M. Lynch, P. Fleming, G.R. Shellam, A.A. Scalzo, and N.J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class 1 homologue in vivo. Nature. 386:510-514.
14. Kurz, S., H.P. Steffens, A. Mayer, J.R. Harris, and M.J. Reddehase. 1997. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:2980-2987.
15. Cuff, S., and J. Ruby. 1996. Evasion of apoptosis by DNA viruses. Immunol. Cell Biol. 74:527-537.
16. Sieg, S., Y. Huang, and D. Kaplan. 1997. Viral regulation of CD95 expression and apoptosis in T lymphocytes. J. Immunol. 159:1192-1199.
17. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature. 370:650-652.
18. Walsh, C.M., M. Matloubian, C.C. Liu, R. Ueda, C.G. Kurahara, J.L. Christensen, M.T. Huang, J.D. Young, R. Ahmed, and W.R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA. 91: 10854-10858.
19. Mountz, J.D., T. Zhou, X. Su, J. Cheng, M. Pierson, H. Bluethmann, and C.K. Edwards III. 1996. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. Behring Institute Mitteilungen. 97:200-219.
20. Stenger, S., R.J. Mazzaccaro, K. Uyemura, S. Cho, P.F. Barnes, J.P. Rosat, A. Sette, M.B. Brenner, S.A. Porcelli, B.R. Bloom, and R.L. Modlin. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science. 276:1684-1687.
21. Cohen, P., and A. Eisenberg. 1992. Autoimmune lpr and gld mice. Ann. Rev. Immunol. 9:243-265.
22. 1 hybrids. J. Autoimmun. 4:595-609.
23. Zhou, T., C.K. Edwards III, P. Yang, Z. Wang, H. Bluethmann, and J.D. Mountz. 1996. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J. Immunol. 156:2661-2665.
24. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
25. Wallach, D. 1997. Placing death under control. Nature. 388:124-126.
26. Lazdins, J.K., M. Grell, M.R. Walker, K. Woods-Cook, P. Scheurich, and K. Pfizenmaier. 1997. Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells. J. Exp. Med. 185:81-90.
27. Ando, K., K. Hiroishi, T. Kaneko, T. Moriyania, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific CTL. J. Immunol 158:5283-5291.
28. Jacob, C.O. 1992. Studies on the role of tumor necrosis factor in murine and human autoimmunity. J. Autoimmun. 5:133-143.
29. Vassalli, P. 1992. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol 10:411-452.
30. Rothstein, T.L., J.K. Wang, D.J. Panka, L.C. Foote, Z. Wang, B. Stanger, H. Cui, S.T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature. 374:163-165.
31. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
32. Ju, S.T., D.J. Panka, H. Cul, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothestein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:444-447.
33. Van Parijs, L., A. Ibraghimov, and A.K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4: 321-328.
34. Sytwu, H.K., R.S. Liblau, and H.O. McDevitt. 1996. The roles of Fas/ APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5:17-30.
35. Kiener, P.A., P.M. Davis, G.C. Starling, C. Mehlin, S.J. Klebanoff, J.A. Ledbetter, and C.W. Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185: 1511-1516.
36. + T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 26:2903-2910.
37. Lohman, B.L., E.S. Razvi, and R.M. Welsh. 1996. T-lymphocyte down-regulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J. Virol. 70:8199-8203.
38. Papiernik, M., C. Pontoux, and P. Golstein. 1995. Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice. Eur. J. Immunol. 25:1517-1523.
39. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:492-501.
40. Schmid, I., C.H. Uittenbogaart, B. Keld, and J.V. Giorgi. 1994. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods. 170:145-157.
41. -T cells with aging. Mech. Ageing Dev. 94:123-134.
42. + T cells in MRL-lpr/lpr mice. J. Immunol. 150:3651-3667.
43. Shellam, G.R., J.E. Allan, J.M. Papadimitriou, and G.J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA. 78:5104-5108.
44. Selgrade, M.K., A.M. Collier, L. Saxton, M.J. Daniels, and J.A. Graham. 1984. Comparison of the pathogenesis of murine cytomegalovirus in lung and liver following intraperitoneal or intratracheal infection. J. Gen. Virol. 65: 515-523.
45. Morahan, P.S., S.S. Morse, and M.B. McGeorge. 1980. Macrophage extrinsic antiviral activity during herpes simplex virus infection. J. Gen. Virol. 46: 291-300.
46. Ruzek, M.C., A.H. Miller, S.M. Opal, B.D. Pearce, and C.A. Biron. 1997. Characterization of early cytokine responses and interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185:1185-1192.
47. Mountz, J.D., T.J. Baker, D.R. Borcherding, H. Bluethman, T. Zhou, and C.K. Edwards III. 1995. Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock. J. Immunol. 155: 4829-4837.
48. Dixon, F.J., M.B. Oldstone, and G. Tonietti. 1969. Virus-induced immune-complex-type glomerulonephritis. Transplant. Proc. 4:945-948.
49. Tonietti, G., M.B. Oldstone, and F.J. Dixon. 1970. The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J. Exp. Med. 132:89-109.
50. Talal, N. 1977. Immunologic and viral factors in autoimmune diseases. Med. Clin. N. Am. 61:205-215.
51. Gardner, M.B., J.N. Ihle, R.J. Pillarisetty, N. Talal, E.L. Dubois, and J.A. Levy. 1977. Type C virus expression and host response in diet-cured NZB/W mice. Nature. 268:341-344.
52. Datta, S.K., N. Manny, C. Andrzejewski, J. Andre-Schwartz, and R.S. Schwartz. 1978. Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice. I. Xenotropic virus. J. Exp. Med. 147:854-871.
53. Haspel, M.V., T. Onodera, B.S. Prabhakar, M. Horita, H. Suzuki, and A.L. Notkins. 1983. Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science. 220:304-306.
54. Zinkernagel, R.M., S. Cooper, J. Chambers, R.A. Lazzarini, H. Hengartner, and H. Arnheiter. 1990. Virus-induced autoantibody response to a transgenic viral antigen. Nature. 345:68-71.
55. Yoshida, H., H. Sumichika, S. Hamano, X. He, Y. Minamishima, G. Kimura, and K. Nomoto. 1995. Induction of apoptosis of T cells by infecting mice with murine cytomegalovirus. J. Virol. 69:4769-4775.
56. Mori, T., K. Ando, K. Tanaka, Y. Ikeda, and Y. Koga. 1997. Fas-mediated apoptosis of hematopoietic progenitor cells in mice infected with murine cytomegalovirus. Blood. 89:3565-3573.
57. Miura, M., H. Zhu, R. Rotello, E.A. Hartwieg, and J. Yuan. 1993. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75:653-660.
58. Tewari, M., L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D.R. Beidler, G.G. Poirier, G.S. Salvesen, and V.M. Dixit. 1995. Yama/CPP32β, a mammalian homolog of ced-3, is a crm-A-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell. 81:801-809.
59. Hawkins, C.J., A.G. Uren, G. Häcker, R.L. Medcalf, and D.L. Vaux. 1996. Inhibition of interleukin 1β-converting enzyme-mediated apoptosis of mammalian cells by baculovirus IAP. Proc. Natl. Acad. Sci. USA. 93:13786-13790.
60. Hashimoto, S., A. Ishii, and S. Yonehara. 1991. The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol. 3:343-351.
61. Zhu, H., Y. Shen, and T. Shenk. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.
62. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.L. Bodmer, M. Schröter, et al. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:517-521.
63. Sieg, S., Z. Yildrim, D. Smith, N. Kayagaki, H. Yagita, Y. Huang, and D. Kaplan. 1996. Herpes simplex virus type 2 inhibition of Fas ligand expression. J. Virol. 70:8747-8751.
64. Dhein, J., H. Walczak, C. Baumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373: 438-441.
65. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Manboubl, F. Echeverre, J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:441-444.
66. Lenardo, M.J. 1996. Fas and the art of lymphocyte maintenance. J. Exp. Med. 183:721-724.
67. Green, D.R., and D.W. Scott. 1994. Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6:476-487.
68. Lehmann, P.V., E.E. Sercarz, T. Forsthuber, C.M. Dayan, and G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today. 14:203-208.
69. Yoon, J.W. 1990. The role of viruses and environmental factors in the induction of diabetes. Cur. Topics Microbiol. Immunol. 164:95-123.
70. Root-Bernstein, R.S. 1995. Preliminary evidence for idiotype-antiidiotype immune complexes cross-reactive with lymphocyte antigens in AIDS and lupus. Medical Hypotheses. 44:20-27.
71. Thorn, J.J., P. Oxholm, and H.K. Andersen. 1988. High levels of complement fixing antibodies against cytomegalovirus in patients with primary Sjögren's syndrome. Clin. Exp. Rheumatol. 6:71-74.
72. Naucler, C.S., S. Larsson, and E. Moller. 1996. A novel mechanism for virus-induced autoimmunity in humans. Immunol. Rev. 152:175-192.
73. Newkirk, M.M., K.N. Watanabe Duffy, J. Leclerc, N. Lambert, and J.B. Shiroky. 1994. Detection of cytomegalovirus, Epstein-Barr virus and herpes virus-6 in patients with rheumatoid arthritis with or without Sjögren's syndrome. Br. J. Rheumatol. 33:317-322.
74. Bartholomaeus, W.N., H. O'Donoghue, D. Foti, C.M. Lawson, G.R. Shellam, and W.D. Reed. 1988. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology. 64:397-405.
75. Jacob, C.O. 1992. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunol Today. 13:122-125.
76. Jacob, C.O., and H.O. McDevitt. 1988. Tumour necrosis factor-alpha in murine autoimmune "lupus" nephritis. Nature. 331:356-358.
77. Price, P., S.D. Olver, A.E. Gibbons, and G.R. Shellam. 1993. B-cell activation following murine cytomegalovirus infection: implications for autoimmunity. Immunology. 78:14-21.
78. Hiromatsu, K., J. Usami, Y. Aoki, M. Makino, and Y. Yoshikai. 1997. Accelerated progression of a murine retrovirus-induced immunodeficiency syndrome in Fas mutant C57BL/6lpr/lpr mice. Microbiol. Immunol. 41:221-227.
79. Toro, A.I., and J. Ossa. 1996. PCR activity of CMV in healthy CMV-sero-positive individuals: does latency need redefinition? Res. Virol. 147:233-238.
80. Reddehase, M.J., M. Balthesen, M. Rapp, S. Jonjic, I. Pavic, and U.H. Koszinowski. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185-193.
81. Kondo, K., H. Kaneshima, and E.S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA. 91:11879-11883.
82. Kondo, K., and E.S. Mocarski. 1995. Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand. J. Infect. Dis. 99:63-67.
83. Koffron, A.J., K.H. Mueller, D.B. Kaufman, F.P. Stuart, B. Patterson, and M.I. Abecassis. 1995. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus. Scand. J. Infect. Dis. 99:61-62.
84. Schmader, K., S.C. Henry, R.J. Rahija, Y. Yu, G.G. Daley, and J.D. Hamilton. 1995. Mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland. J. Infect. Dis. 172:531-534.
85. Collins, T., C. Pomeroy, and M.C. Jordan. 1993. Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168:725-729.
86. Kurz, S., H.P. Steffens, A. Mayer, J.R. Harris, and M.J. Reddehase. 1997. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:2980-2987.